Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dill

Showing results (431-440 of 435) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 435 results.
JCI Insight|March 9, 2026
Human iPSC-derived alveolar macrophages reveal macrophage subtype functions of itaconate in M. tuberculosis defenseAdam S Krebs, Tomi Lazarov, Anthony T Reynolds, et al.
JAMA Pediatrics|July 14, 2025
Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children: A Secondary Analysis of a Randomized Clinical TrialMatthew C Altman, Tomasz Janczyk, Ryan C Murphy, et al.
Journal of Research of the National Institute of Standards and Technology|August 26, 2021
The Nanolithography ToolboxKrishna C Balram, Daron A Westly, Marcelo Davanço, et al.
Lancet (London, England)|August 14, 2022
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trialDaniel J Jackson, Leonard B Bacharier, Peter J Gergen, et al.
Nature Methods|February 5, 2021
Cryo-EM model validation recommendations based on outcomes of the 2019 EMDataResource challengeCatherine L Lawson, Andriy Kryshtafovych, Paul D Adams, et al.
Pageof 44

Showing results (431-440 of 435) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 435 results.
JCI Insight|March 9, 2026
Human iPSC-derived alveolar macrophages reveal macrophage subtype functions of itaconate in M. tuberculosis defenseAdam S Krebs, Tomi Lazarov, Anthony T Reynolds, et al.
JAMA Pediatrics|July 14, 2025
Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children: A Secondary Analysis of a Randomized Clinical TrialMatthew C Altman, Tomasz Janczyk, Ryan C Murphy, et al.
Journal of Research of the National Institute of Standards and Technology|August 26, 2021
The Nanolithography ToolboxKrishna C Balram, Daron A Westly, Marcelo Davanço, et al.
Lancet (London, England)|August 14, 2022
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trialDaniel J Jackson, Leonard B Bacharier, Peter J Gergen, et al.
Nature Methods|February 5, 2021
Cryo-EM model validation recommendations based on outcomes of the 2019 EMDataResource challengeCatherine L Lawson, Andriy Kryshtafovych, Paul D Adams, et al.
Pageof 44